David Conway
MRC Laboratories, Fajara, Gambia
David Conway is a MalariaGEN Investigator and Head of the Malaria Research Programme at the MRC Laboratories, The Gambia. He leads ongoing clinical studies of severe malaria and malaria vaccine trials in The Gambia. David has worked on other aspects of malaria, as well as other infectious diseases such as trachoma and strongyloidiasis, and enjoys working on different systems.
Prior to moving to The Gambia in 2005, David ran an MSc Study Unit entitled 'Genetics of Pathogens and Vectors' for 9 years, and taught on the Study Units 'Genetic Epidemiology', and 'Immunology of Parasitic Infections', and on the Distance Learning module on Malaria.
David Conway and his team are contributing to Consortial Project 1 and Consortial Project 3. More >>
Relevant external links
- Publication: Plasmodium falciparum merozoite surface protein 3 is a target of allele-specific immunity and alleles are maintained by natural selection
- Publication: Molecular epidemiology of malaria
- Publication: Expression of Plasmodium falciparum genes involved in erythrocyte invasion varies among isolates cultured directly from patients
- Publication: Contrasting signatures of selection on the Plasmodium falciparum erythrocyte binding antigen gene family.